Why Pacific Biosciences of California Hit a Speed Bump With Its Q3 Results

Pacific Biosciences of California (NASDAQ:PACB) stock has been on a tear, more than tripling in just the last three months. It definitely helped that a top analyst, J.P. Morgan's Tycho Peterson, raised his price target for PacBio from $5 to $15 early last month.